Your browser doesn't support javascript.
loading
Clopidogrel and CYP2C19: pharmacogenetic testing ready for clinical prime time?
Knauer, Michael J; Diamandis, Eleftherios P; Hulot, Jean-Sebastien; Kim, Richard B; So, Derek Y F.
Afiliação
  • Knauer MJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;
  • Diamandis EP; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; ediamandis@mtsinai.on.ca.
  • Hulot JS; Director of Pharmacogenomics & Personalized Therapeutics, Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai School, New York, NY;
  • Kim RB; Professor of Medicine, Physiology and Pharmacology, and Oncology, Wolfe Medical Research, Chair in Pharmacogenomics, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada;
  • So DY; Program Director, Adult Interventional Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Clin Chem ; 61(10): 1235-40, 2015 Oct.
Article em En | MEDLINE | ID: mdl-26272232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Ticlopidina / Inibidores da Agregação Plaquetária / Pró-Fármacos / Citocromo P-450 CYP2C19 Limite: Humans Idioma: En Revista: Clin Chem Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Ticlopidina / Inibidores da Agregação Plaquetária / Pró-Fármacos / Citocromo P-450 CYP2C19 Limite: Humans Idioma: En Revista: Clin Chem Ano de publicação: 2015 Tipo de documento: Article